Partner

Articles & Insights / Data Integrity

Data Integrity Across the Laboratory Result Lifecycle

A laboratory result is reliable when the underlying records allow its generation, processing and review to be reconstructed. Data integrity therefore depends on everyday workflows and system controls as much as on the final certificate of analysis.

Stabicon Life Sciences3 min read

Accreditations, approvals & registrations

  • Prequalified by WHO, Geneva

    One of the Only 6 Commercial Testing Facilities in India to have a WHO Geneva Approval

  • Accredited by ISO/IEC 17025:2017 (NABL)

  • Approved by FSSAI

  • Approved by CDSCO, India

  • Facility Registered with FDA, Karnataka

  • Registered with DSIR

  • Registered with AYUSH

All articles

What this article helps you consider

  • Define the complete record
  • Map how the result is created
  • Control access and changes

Define the complete record

An analytical record can include sample receipt, preparation observations, weights, instrument files, acquisition settings, processing methods, calculations and review. Metadata provide the context needed to interpret these records. A printed chromatogram or PDF may omit information retained in the original electronic system.

FDA’s drug-CGMP data-integrity guidance supports risk-based strategies for reliable and accurate data. These pharmaceutical expectations should be identified with their scope. Other laboratory sectors can apply similar principles through their own accreditation, regulatory and contractual frameworks. R52

Map how the result is created

Follow the actual workflow from sample registration to approval and retention. Identify manual transcription, spreadsheets, interfaces and points where information can be altered or lost. The illustration presents this lifecycle and shows that record retention begins when data are generated, rather than after a report is signed.

Explore the scienceData Integrity

A report is supported by a complete record set

Record setEvidence retained
Sample & preparationIdentity, weights, observations
AcquisitionRaw files, settings, metadata
Processing & reviewMethods, calculations, changes
Retention & retrievalComplete records that can be restored

Traceable originals + relevant change history + review rationale

Sample & preparation

Preserve identity, actual weights, preparation observations and relevant timing.

Conceptual explanation. No product result, acceptance criterion or universal regulatory sequence is established by this illustration.

Complete records extend from sample preparation through acquisition, processing, review and retrieval. The list is a conceptual record map, not an exhaustive system-validation checklist.

A hypothetical laboratory might preserve final instrument files but overwrite a spreadsheet used to calculate the result. The report would then lack part of its supporting record. Assess each system according to the role it plays in the quality decision, including apparently simple utilities.

Control access and changes

Use individual accounts and roles appropriate to responsibilities. Shared credentials weaken attribution. Separate routine analytical permissions from administrative functions where appropriate, and manage account creation, changes and removal. A technically available audit trail provides little value if users can disable it without control.

Define which changes require explanation and review. Reprocessing, altered integration and changed sample sequences can be legitimate, but their history must remain available. A clean final chromatogram should not conceal discarded attempts, deleted data or unexplained processing decisions.

Review the underlying evidence

The reviewer should assess the relevant original records and changes, not only the final reported numbers. Review procedures should identify which audit trails and metadata are relevant, how they are examined and what findings trigger investigation. The depth of review should reflect data criticality and system risk.

An outlying injection cannot be omitted solely because it makes a batch average less convenient. If an injection or preparation is invalidated, preserve the evidence and the scientific rationale. Consistent records allow legitimate laboratory problems to be distinguished from selective reporting.

Demonstrate retention and retrieval

Backups support recovery after failure, while archives preserve records for the required retention period. The two functions overlap but are not identical. Test whether retained data can be restored and interpreted with the necessary software, methods and metadata.

Electronic signatures and access controls also depend on system configuration, validation, procedures and training. Purchasing software described as compliant does not by itself establish compliance with 21 CFR Part 11 or other applicable requirements. Evaluate the actual implementation and record scope. R53

Make good practice workable

Timely recording requires practical forms, suitable equipment access and realistic staffing. A system that encourages unofficial notebooks or later reconstruction creates avoidable risk. Provide clear escalation routes when an error occurs so that corrections remain traceable and analysts do not feel pressure to hide a problem.

Stabicon can support complete analytical records and clearly defined reporting packages within the agreed project scope. Clients should establish data ownership, access, retention and review responsibilities in their laboratory and quality agreements.

References & further reading

Read the source in its stated scope. Requirements, amendments and compendial editions depend on the product and target market. Draft guidance is identified separately.

  1. R52
    FDA Data Integrity and Compliance with Drug CGMP

    Final questions and answers, December 2018. Pharmaceutical scope.

  2. R53
    FDA Part 11 Electronic Records and Electronic Signatures

    Final scope-and-application guidance, August 2003. Apply together with underlying record requirements.

From insight to a defined programme

Bring your next technical question.

Share your formulation, testing objective or development challenge. Stabicon can review the context and define a suitable scope of work.

Discuss this topic with Stabicon

Continue reading

Related scientific perspectives.

Stabicon Life Sciences

Science-Led Formulations. Scalable Health Platforms.

Offices

Corporate Office

22, 7th Cross, Jaibharath Nagar, Bengaluru 560 033, Karnataka, India

Research & Development

28, Bommasandra Industrial Area, 4th Phase, Jigani Hobli, Anekal Taluk, Bengaluru 560 099, Karnataka, India

Newsletter

Quarterly briefings on platforms, science & partnerships.

No spam. Request a consent withdrawal at bd@stabicon.com.

Press Kit

Logos, company information & spokesperson details – available from our media team.

Request Press Kit

Accreditations

Prequalified by WHO, GenevaAccredited by ISO/IEC 17025:2017 (NABL)Approved by FSSAIApproved by CDSCO, IndiaFacility Registered with FDA, KarnatakaRegistered with DSIRRegistered with AYUSHOne of the Only 6 Commercial Testing Facilities in India to have a WHO Geneva Approval

Disclaimer: The information provided on this website is for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease. Product packaging and materials may vary from those shown on our website. We recommend that you do not rely solely on the information presented and that you always read labels, warnings, and directions before using or consuming a product.

© 2026 Stabicon Life Sciences Pvt. Ltd. All rights reserved.

Science-Led Formulations. Scalable Health Platforms.

Admin